Genelux Corporation
USD2.93
+0.06 (+2.09%)
CEO
Thomas D. Zindrick
IPO Date
2023-01-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.87
Prev. Close
$2.87
Day Low
$2.77
Day High
$2.96
52W Low
$2.29
52W High
$8.54
Market Cap
$0.11B
Volume
0.17M
| 278,906 |
| $0.00 |
| 18 Jun 2026 | Groen Eric | General Counsel | A-Award | Acquired | 233,957 | $0.00 |
| 18 Jun 2026 | Cappello Joseph | Chief Technical Officer | A-Award | Acquired | 174,841 | $0.00 |
| 18 Jun 2026 | Tyree James L | director | A-Award | Acquired | 28,409 | $0.00 |
| 18 Jun 2026 | Tyree James L | director | A-Award | Acquired | 31,566 | $3.03 |
| 18 Jun 2026 | Zindrick Thomas | President and CEO | A-Award | Acquired | 730,601 | $0.00 |
| 18 Jun 2026 | Thomas John | director | A-Award | Acquired | 28,409 | $0.00 |
| 18 Jun 2026 | Thomas John | director | A-Award | Acquired | 31,566 | $3.03 |
| 18 Jun 2026 | Mirabelli Mary | director | A-Award | Acquired | 28,409 | $0.00 |